...
首页> 外文期刊>Therapeutic Drug Monitoring >Low Serum Trough Concentrations and High Vancomycin Minimum Inhibitory Concentration in Methicillin-Sensitive Staphylococcus aureus From Hemodialysis Patients in Brazil
【24h】

Low Serum Trough Concentrations and High Vancomycin Minimum Inhibitory Concentration in Methicillin-Sensitive Staphylococcus aureus From Hemodialysis Patients in Brazil

机译:巴西血液透析患者的低血清槽浓度和高万霉素最小抑制素甲氧西林敏感葡萄球菌中的抑制浓度

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The empiric antimicrobial therapy for bacteremia of long-term hemodialysis (HD) outpatients is currently based on the combination of vancomycin and gentamicin because of the high frequency of isolated Staphylococcus species. The vancomycin trough level range from 15 to 20 mcg/mL is expected for therapeutic success against methicillin-resistant Staphylococcus aureus with vancomycin minimum inhibitory concentration (MIC) >= 1.0 mcg/mL. Despite the availability of clinical practice guidelines for vancomycin therapeutic drug monitoring, these target serum concentrations are not reached in many patients.
机译:背景:长期血液透析(HD)门诊患者的肌菌抗菌治疗目前是基于万古霉素和庆大霉素的组合,因为分离的葡萄球菌物种的高频率。 预期15至20mcg / ml的万古霉素槽水平范围为抗甲氧西林抗性金黄色葡萄球菌的治疗成功,具有万古霉素最小抑制浓度(MIC)> = 1.0mcg / ml。 尽管有临床实践指南的万古霉素治疗药物监测,但许多患者未达到这些靶标血清浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号